Cori Gray, PharmD

Cori Gray, PharmD

Cori Gray is a recent graduate of the University of Maryland School of Pharmacy (UMSOP). While at UMSOP, she was a research assistant for Professor Julia F Slejko where she contributed to projects related to formulary restrictions to COPD medication, statin prescribing trends, and patient preference in cost-effectiveness analyses in COPD. She was previously a Post-Doctoral Fellow at the Pharmaceutical Research and Manufacturers of America (PhRMA) during her third year of pharmacy school.

She is currently a Post-Doctoral Health Economics & Value Assessment Fellow at Sanofi and Adjunct Faculty Member at Rutgers University’s Ernest Mario School of Pharmacy, in Piscataway, New Jersey. She is pursuing a Master’s degree in Health Outcomes, Policy, and Economics at Rutgers School of Public Health. She supports Diabetes, Rare Blood Disorders, Multiple Sclerosis, Immunology and Oncology products at Sanofi. In addition, she supports the Global and US HTA Strategy team.